Insider Transactions in Q1 2023 at Alkermes Plc. (ALKS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,961
-7.19%
|
$54,908
$28.07 P/Share
|
|
Feb 18
2023
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,230
+18.6%
|
-
|
|
Feb 18
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,965
-2.97%
|
$55,020
$28.07 P/Share
|
|
Feb 18
2023
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,230
+8.61%
|
-
|
|
Feb 18
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,656
-9.94%
|
$74,368
$28.07 P/Share
|
|
Feb 18
2023
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,722
+24.61%
|
-
|
|
Feb 10
2023
|
David Angelo Daglio Jr. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,445
+22.66%
|
-
|
|
Feb 10
2023
|
Brian P Mckeon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,445
+22.66%
|
-
|